Skip to main content

Table 1 Univariate analysis of the association of exposure to qualitative variables and 14- and 30-day mortality

From: Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study

Variable

No. dead at day 14 (%)

RR(95% CI)

P value

No. dead at day 30 (%)

RR (95% CI)

P value

Gender

Male

34 (17)

Ref.

-

42 (22)

Ref.

-

Female

22 (15)

0.9 (0.5–1.4)

0.56

27 (18)

0.9 (0.6–1.3)

0.4

Type of acquisition

Community

22 (15)

Ref

-

29 (19)

Ref.

-

HCA

34 (18)

1.2 (0.7–2.0)

0.47

41 (21)

1.1 (0.7–1.7)

0.7

Type of hospital

Tertiary

38 (15)

Ref.

-

51 (20)

Ref.

-

Community

18 (21)

1.4 (0.8–2.3)

0.2

19 (22)

1.1 (0.7–1.7)

0.7

Neutropenia

No

49 (15)

Ref.

-

61 (19)

Ref.

-

Yes

7 (47)

3.1 (1.7–5.6)

0.001

9 (60)

3.2 (2.0–5.1)

<0.001

ICU admission

No

46 (14)

Ref.

-

61 (13)

Ref.

-

Yes

10 (45.5)

3.1 (1.9–5.4)

<0.001

9 (41)

2.1 (1.2–3.7)

0.01

Severity of SISR

Sepsis

19 (7.8)

Ref.

-

325 (13.1)

Ref.

-

Severe sepsis or shock

37 (38.5)

5.0 (3.0-8.3)

<0.001

38/54 (39.6)

3.03 (2.0–4.5)

<0.001

Source of bacteremia

Vascular catheter

1 (4)

Ref.

-

2 (8)

Ref.

-

Urinary tract

7 (8)

1.9 (0.2–14.9)

0.5

9 (10)

1.3 (0.2–9.2)

1

Intraabdominal

12 (18)

4.1 (0.6–29.6)

0.1

17 (24)

2.9 (0.7–11.5)

0.1

Other source

9 (21)

4.9 (0.7–36.5)

0.1

10 (23)

2.7 (0.7–11.4)

0.2

Unknown

15 (23)

5.5 (0.8–39.7)

0.1

19 (29)

4.5 (0.9–30.1)

0.1

Respiratory tract

12 (25)

6.0 (0.8–43.5)

0.05

13 (27)

3.2 (0.8–13.2)

0.1

Etiology

CONS

1 (4)

Ref.

-

2 (8)

Ref.

-

K. pneumoniae

2 (8)

2.0 (0.2–20.6)

1

4/(17)

2.0 (0.4-)

0.7

E. coli

13 (10.5)

2.5 (0.3–18.3)

0.5

17 (14)

1.7 (0.4–6.7)

0.7

S. aureus

7 (22)

5.2 (0.7–39.9)

0.1

8 (25)

3.0 (0.7-12.9)

0.2

S. pneumoniae

8 (22)

5.3 (0.7–39.9)

0.1

10 (28)

3.3 (0.8–13.9)

0.1

Enterococcus spp.

3 (23)

5.5 (0.7–48.0)

0.1

3 (23)

2.8 (0.5–14.5)

0.2

Enterobacter spp

2 (22)

5.3 (0.5–1.9)

0.2

3 (33)

4.0 (0.8–20.1)

0.1

P. aeruginosa

5 (36)

8.6 (1.1–66.1)

0.02

6 (43)

5.1 (1.2–22.1)

0.03

Empirical therapy

Adequate

40 (14)

Ref.

-

53 (19)

Ref.

-

Inadequate

16 (28)

2.0 (1.2–3.3)

0.01

17 (30)

1.6 (1.0–2.5)

0.1

  1. RR relative risk, CI confidence interval, Ref reference, HCA healthcare-associated, SIRS systemic inflammatory response syndrome, ICU intensive care unit, CONS coagulase-negative staphylococci.